Experience

Cooley Secures Win for Liquidia to Launch First Product

April 5, 2024

Cooley successfully lifted a Hatch-Waxman injunction for Liquidia Technologies, a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products, enabling Liquidia to launch its new drug, Yutrepia.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Ivor Elrifi
Partner, New York
Daniel Knauss
Partner, Palo Alto
Adam Pivovar
Partner, Washington, DC
Brittany Cazakoff
Associate, Washington, DC
Robert Minn
Associate, Palo Alto
Lauren Strosnick
Associate, Palo Alto
Jennifer Volk-Fortier
Associate, Washington, DC
Sam Whitt
Associate, Washington, DC
Larissa Diaz
Senior Paralegal, Washington, DC
Jeannine Douglas
Paralegal Specialist, Palo Alto
Melissa Eskola
Paralegal Specialist, Reston
Loreylys Feliciano
Paralegal Specialist, Chicago
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Blue Owl Capital Invests up to $1.05 Billion in BridgeBio Pharma

January 17, 2024

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Michael Tollini
Partner, Washington, DC
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Ivor Elrifi
Partner, New York
Xander Lee
Partner, Los Angeles Santa Monica
Geoffrey Spolyar
Partner, Boston
Jon Cousin
Partner, Washington, DC
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Michael Egan
Partner, Washington, DC
Jeffrey J. Tolin
Partner, New York
Michael Klein
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Cathy Hershcopf
Senior Counsel, New York
Stevie Yu
Associate, New York
Yichao Zhang
Associate, New York
Rodrigo Huerta
Associate, Chicago
Jackson Alldredge
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Celine Koh
Associate, Palo Alto
Jameson Davis
Associate, Boston
Allison Kutner
Associate, New York
Matthew S. Scarano
Associate, San Diego
Xueqing Li
Associate, San Francisco
Mor Agam
Associate, New York
Miriam Peguero Medrano
Associate, Chicago
Sam Rabuck
Associate, Chicago
Chris Rhem
Paralegal Specialist, San Francisco
Veronica Cortes
Paralegal Specialist, New York
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Blue Owl Capital Invests up to $140 Million in XOMA Corporation

December 19, 2023

Cooley advised Blue Owl Capital, a top asset manager that is redefining alternatives, on its strategic investment – consisting of a nondilutive, nonrecourse royalty-backed loan of up to $140 million – in XOMA Corporation, a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Xander Lee
Partner, Los Angeles Santa Monica
Geoffrey Spolyar
Partner, Boston
Ivor Elrifi
Partner, New York
Michael Klein
Partner, New York
Annie Froehlich
Partner, Washington, DC
Yichao Zhang
Associate, New York
Xueqing Li
Associate, San Francisco
Patrick Sharma
Associate, Los Angeles Santa Monica
Cameron Hajialiakbar
Associate, Los Angeles Santa Monica
Evan Lazerowitz
Associate, New York
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, Boston
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

VectivBio to be Acquired by Ironwood

May 23, 2023

Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by Ironwood, with an estimated aggregate consideration of approximately $1 billion.

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Rita Sobral
Associate, London
Sydney Sawyier
Associate, London
Vlad Herta
Associate, London
Sarah Curry
Associate, New York
Trevor Bossi
Associate, Boston
Lois NaYeon Yoo
Associate, New York
Ofir Hadari
Associate, New York
David Burns
Special Counsel, Washington, DC
Nicollette R. Kirby
Associate, Washington, DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Mary Maher Lewis
Special Counsel, Reston
Steven A. Zuckerman
Associate, New York
Stephanie Gentile
Partner, New York
Eileen Marshall
Partner, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Ivor Elrifi
Partner, New York
Heidi A. Erlacher
Partner, Boston
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Megan Flynn
Associate, London
Joe Claffey
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

View more

Admissions & credentials

California

Massachusetts

New York

Ontario, Canada

US Patent and Trademark Office

Rankings & accolades

Chambers USA: Intellectual Property: Patent – New York (2021 – 2023)

Euromoney: Global Leader in Patent Law

Fellows of the American Bar Foundation: Elected Member

IAM Patent 1000: Leading Patent Lawyer

The Legal 500 US: Leading Lawyer in Healthcare: Lifesciences (2023)

LMG Life Sciences: Life Sciences Star, "Patent Strategy Attorney of the Year" (Winner, 2019; Finalist, 2020 - 2023)

Managing Intellectual Property: IP Star

Super Lawyers: Top IP Lawyer

Patent Strategy & Management Attorney of the Year

LMG Life Sciences, 2019